Shunichi Sugawara

31PUBLICATIONS
192CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyHaematological tumoursLiquid biopsiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jul 27, 2026
Efficacy and safety of necitumumab and pembrolizumab combination therapy in advanced non-small-cell lung cancer with ≥50% PD-L1 expression: A nonrandomized phase II trial.

|Apr 09, 2026
Impact of tumor location on the efficacy of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer.

Yuichi Ozawa, Kouji Yamamoto, Shunichi Sugawara

|Jan 29, 2026
Four-Year Outcomes for Nivolumab With Chemotherapy and Bevacizumab in Patients With Nonsquamous NSCLC in the TASUKI-52.

Jong-Seok Lee, Shunichi Sugawara, Jin-Hyoung Kang

|Jan 13, 2026
Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer.

Glenwood D Goss, Gail E Darling, Virginie Westeel

|Dec 23, 2025
Perioperative Nivolumab in Resectable Non-Small Cell Lung Cancer: A Subanalysis of Japanese Patients From CheckMate 77T.

Fumihiro Tanaka, Yasutaka Watanabe, Shunichi Sugawara

|Dec 19, 2025
IMpower010: 5-Year Outcomes of Atezolizumab in Japanese Patients With Resected Stage IB-IIIA Non-Small Cell Lung Cancer.

Morihito Okada, Shunichi Sugawara, Yasutaka Watanabe

Pageof 6

Frequent Collaborators

5 joint publications

Isamu Okamoto

5 joint publications

Kazuhiko Nakagawa

4 joint publications

Hidehito Horinouchi

4 joint publications

Tetsuya Mitsudomi